US › Healthcare

Hyperion DeFi, Inc. (HYPD)

US · Healthcare · Biotechnology

$2.84-9.84%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$357,693

Net profit

$31.0M

EPS

$0.92

EPS estimate

$2.24

Net margin

8,652.9%

EPS came in at 0.92 against a street estimate of 2.24 — a miss of 58.9%.

Key statistics

Market cap

$51.1M

Forward P/E

0.0

P/B

0.60

Book value

$6.66

EPS (TTM)

$-6.46

52-week high

$9.13

52-week low

$2.34

50-day MA

$3.35

200-day MA

$3.40

Beta

2.52

Analyst view

Analysts rate Hyperion DeFi, Inc. a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $9.82.

Shareholding

Insiders

5.33%

Institutions

18.72%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	3.02%
Franklin Templeton Inc	2.56%
Arrington Capital Management, LLC	1.93%
Morgan Stanley - Brokerage Accounts	1.54%
Redwood Wealth Management Group LLC	1.19%
Almanack Investment Partners, LLC.	1.09%
Geode Capital Management, LLC	0.85%
Jane Street Group LLC	0.83%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Hyperion DeFi, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.